Dupixent

Dupixent is an injectable interleukin-4 receptor alpha (IL-4a) antagonist developed by Regeneron Pharmaceuticals. In March of 2017, the FDA first authorized Dupixent (dupilumab) for the use in treatment of Eczema in adults. Currently, Duxpixent is used for the treatment of moderate to severe atopic dermatitis and asthma, and as an add-on treatment for chronic rhinosinusitis… Continue reading Dupixent

My Dissertation Project

The focus of my project is to understand how alternative splicing of centrosomal protein, Ninein, modulates ethanol’s anxiolytic properties. Ninein was identified as a candidate gene underlying the quantitative trait loci (QTL) generated in our Etanq1 paradigm: the effect of an acute injection of ethanol on behavior in the Light-Dark Transitional Model of anxiety. My… Continue reading My Dissertation Project

Hello world!

Welcome to Rampages.us. This is your first post. Does it make you sad you didn’t write it? You can change that. Write something better. Change the world. You are lucky enough to be in a position to do that. Make the most of it.